Spiral Therapeutics Begins Phase 1 Trial of Hearing Loss Drug

Spiral Therapeutics Begins Phase 1 Trial of Hearing Loss Drug
  • December 28, 2018
  • News

Spiral Therapeutics, a clinical stage pharmaceutical company focused on the development of first-in-class therapies targeting inner ear disorders, announced the initiation of its Phase 1 clinical trial of LPT99, the company‚Äôs lead investigational drug candidate targeting prevention and treatment of hearing loss.

Read more: http://www.hearingreview.com/2018/12/spiral-therapeutics-begins-phase-1-trial-hearing-loss-drug

Close Menu